ArticleMultiple sclerosis international2015
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Article in Multiple sclerosis international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.Journal of neurology · 2017Pooled it
- Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.Neurology · 2023Trial
- Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024Review
- Recurrent Self Fusion: Iterative Denoising for Consistent Retinal OCT Segmentation.Ophthalmic medical image analysis : 10th International Workshop, OMIA 2023, held in conjunction with MICCAI 2023, Vancouver, BC, Canada, October 12, 2023, Proceedings. OMIA (Workshop) (10th : 2023 : Vancouver, B.C. ; Online) · 2023Article
- Longitudinal deep network for consistent OCT layer segmentation.Biomedical optics express · 2023Article
- Trans-Synaptic Degeneration Following Acute Optic Neuritis in Multiple Sclerosis.Annals of neurology · 2023Article
- Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple Sclerosis.Neurology(R) neuroimmunology & neuroinflammation · 2022Observational
- Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.Journal of neurology, neurosurgery, and psychiatry · 2022Article
- Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism.Cell reports. Medicine · 2021Article
- Structured layer surface segmentation for retina OCT using fully convolutional regression networks.Medical image analysis · 2021Article
- Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.Annals of neurology · 2020Article
- Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.Multiple sclerosis (Houndmills, Basingstoke, England) · 2020Article
- Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2020Observational
- Testing a phantom eye under various signal-to-noise ratio conditions using eleven different OCT devices.Biomedical optics express · 2020Article
- Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis.Frontiers in neurology · 2020Article
- Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.Multiple sclerosis (Houndmills, Basingstoke, England) · 2019Article
- Deep learning based topology guaranteed surface and MME segmentation of multiple sclerosis subjects from retinal OCT.Biomedical optics express · 2019Article
- Layer boundary evolution method for macular OCT layer segmentation.Biomedical optics express · 2019Article
- Retinal layer parcellation of optical coherence tomography images: Data resource for multiple sclerosis and healthy controls.Data in brief · 2019Article
- Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.Brain : a journal of neurology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background. The lack of segmentation algorithms operative across optical coherence tomography (OCT) platforms hinders utility of retinal layer measures in MS trials. Objective. To determine cross-sectional and longitudinal agreement of retinal layer thicknesses derived from an open-source, fully-automated, segmentation algorithm, applied to two spectral-domain OCT devices. Methods. Cirrus HD-OCT and Spectralis OCT macular scans from 68 MS patients and 22 healthy controls were segmented. A longitudinal cohort comprising 51 subjects (mean follow-up: 1.4 ± 0.9 years) was also examined. Bland-Altman analyses and interscanner agreement indices were utilized to assess agreement between scanners. Results. Low mean differences (-2.16 to 0.26 μm) and narrow limits of agreement (LOA) were noted for ganglion cell and inner and outer nuclear layer thicknesses cross-sectionally. Longitudinally we found low mean differences (-0.195 to 0.21 μm) for changes in all layers, with wider LOA. Comparisons of rate of change in layer thicknesses over time revealed consistent results between the platforms. Conclusions. Retinal thickness measures for the majority of the retinal layers agree well cross-sectionally and longitudinally between the two scanners at the cohort level, with greater variability at the individual level. This open-source segmentation algorithm enables combining data from different OCT platforms, broadening utilization of OCT as an outcome measure in MS trials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.